ACTAVIS LAUNCHES DIABETES TABLETS IN MALTA

A A

Following the successful launch of generic Glimepiride in a number of European markets, Actavis Limited launched its product in Malta. Glimepiride is indicated for the treatment of diabetes, where the increased blood glucose cannot be adequately controlled by diet, physical exercise and weight reduction. In a press release, the company explained that it has launched Glimepiride into a number of EU markets last December to coincide with the expiry of the originator's patent.
MaltaMedia